BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 25751629)

  • 1. Better informing decision making with multiple outcomes cost-effectiveness analysis under uncertainty in cost-disutility space.
    McCaffrey N; Agar M; Harlum J; Karnon J; Currow D; Eckermann S
    PLoS One; 2015; 10(3):e0115544. PubMed ID: 25751629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presenting evidence and summary measures to best inform societal decisions when comparing multiple strategies.
    Eckermann S; Willan AR
    Pharmacoeconomics; 2011 Jul; 29(7):563-77. PubMed ID: 21671686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health technology assessment in the cost-disutility plane.
    Eckermann S; Briggs A; Willan AR
    Med Decis Making; 2008; 28(2):172-81. PubMed ID: 18356312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A MEA is a MEA is a MEA? Sequential decision making and the impact of different managed entry agreements at the manufacturer and payer level, using a case study for an oncology drug in England.
    Buyukkaramikli NC; Wigfield P; Hoang MT
    Eur J Health Econ; 2021 Feb; 22(1):51-73. PubMed ID: 32901420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold.
    Claxton K; Martin S; Soares M; Rice N; Spackman E; Hinde S; Devlin N; Smith PC; Sculpher M
    Health Technol Assess; 2015 Feb; 19(14):1-503, v-vi. PubMed ID: 25692211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of alternative strategies for the initial medical management of non-ST elevation acute coronary syndrome: systematic review and decision-analytical modelling.
    Robinson M; Palmer S; Sculpher M; Philips Z; Ginnelly L; Bowens A; Golder S; Alfakih K; Bakhai A; Packham C; Cooper N; Abrams K; Eastwood A; Pearman A; Flather M; Gray D; Hall A
    Health Technol Assess; 2005 Jul; 9(27):iii-iv, ix-xi, 1-158. PubMed ID: 16022802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value-of-information analysis to reduce decision uncertainty associated with the choice of thromboprophylaxis after total hip replacement in the Irish healthcare setting.
    McCullagh L; Walsh C; Barry M
    Pharmacoeconomics; 2012 Oct; 30(10):941-59. PubMed ID: 22667458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone-anchored hearing aids (BAHAs) for people who are bilaterally deaf: a systematic review and economic evaluation.
    Colquitt JL; Jones J; Harris P; Loveman E; Bird A; Clegg AJ; Baguley DM; Proops DW; Mitchell TE; Sheehan PZ; Welch K
    Health Technol Assess; 2011 Jul; 15(26):1-200, iii-iv. PubMed ID: 21729632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effectiveness and cost-effectiveness of hospital-based specialist palliative care for adults with advanced illness and their caregivers.
    Bajwah S; Oluyase AO; Yi D; Gao W; Evans CJ; Grande G; Todd C; Costantini M; Murtagh FE; Higginson IJ
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD012780. PubMed ID: 32996586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure.
    McKenna C; Burch J; Suekarran S; Walker S; Bakhai A; Witte K; Harden M; Wright K; Woolacott N; Lorgelly P; Fenwick L; Palmer S
    Health Technol Assess; 2010 May; 14(24):1-162. PubMed ID: 20492762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prioritizing Research Informing Antibiotic Prophylaxis Guidelines for Knee Arthroplasty Patients.
    Kuntz KM; Alarid-Escudero F; Swiontkowski MF; Skaar DD
    JDR Clin Trans Res; 2022 Jul; 7(3):298-306. PubMed ID: 34137291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk-based, 6-monthly and 24-monthly dental check-ups for adults: the INTERVAL three-arm RCT.
    Clarkson JE; Pitts NB; Goulao B; Boyers D; Ramsay CR; Floate R; Braid HJ; Fee PA; Ord FS; Worthington HV; van der Pol M; Young L; Freeman R; Gouick J; Humphris GM; Mitchell FE; McDonald AM; Norrie JD; Sim K; Douglas G; Ricketts D
    Health Technol Assess; 2020 Nov; 24(60):1-138. PubMed ID: 33215986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methods for Communicating the Impact of Parameter Uncertainty in a Multiple-Strategies Cost-Effectiveness Comparison.
    Wolff HB; Qendri V; Kunst N; Alarid-Escudero F; CoupΓ© VMH
    Med Decis Making; 2022 Oct; 42(7):956-968. PubMed ID: 35587181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; MenΓ©ndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moving Beyond Quality-Adjusted Life-Years in Elderly Care: How Can Multicriteria Decision Analysis Complement Cost-Effectiveness Analysis in Local-Level Decision Making.
    Hoedemakers M; Tsiachristas A; Rutten-van MΓΆlken M
    Value Health; 2022 Oct; 25(10):1717-1725. PubMed ID: 35623974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of assumptions on future costs, disutility and mortality in cost-effectiveness analysis; a model exploration.
    Omidvari AH; Lansdorp-Vogelaar I; de Koning HJ; Meester RGS
    PLoS One; 2021; 16(7):e0253893. PubMed ID: 34252090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(13):1-214. PubMed ID: 34484487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modelling of hypothetical SARS-CoV-2 point of care tests for routine testing in residential care homes: rapid cost-effectiveness analysis.
    Stevenson M; Metry A; Messenger M
    Health Technol Assess; 2021 Jun; 25(39):1-74. PubMed ID: 34142943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Including quality attributes in efficiency measures consistent with net benefit: creating incentives for evidence based medicine in practice.
    Eckermann S; Coelli T
    Soc Sci Med; 2013 Jan; 76(1):159-68. PubMed ID: 23153543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-Effectiveness Analysis in Telehealth: A Comparison between Home Telemonitoring, Nurse Telephone Support, and Usual Care in Chronic Heart Failure Management.
    Grustam AS; Severens JL; De Massari D; Buyukkaramikli N; Koymans R; Vrijhoef HJM
    Value Health; 2018 Jul; 21(7):772-782. PubMed ID: 30005749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.